Another study showed that IL7R promoted the sensitivity of non-small cell lung cancer (NSCLC) cells by activating the IL-7R-JAK3/STAT5 signaling pathway to cisplatin, and inhibited tumor growth[27]. The gene discussed is IL7R; the disease is non-small cell lung carcinoma.